COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance
A Achar, C Ghosh - Cells, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …
The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms
Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …
Cognitive decline following acute viral infections: literature review and projections for post-COVID-19
RF Damiano, BF Guedes, CC de Rocca… - European archives of …, 2022 - Springer
Recently, much attention has been drawn to the importance of the impact of infectious
disease on human cognition. Several theories have been proposed, to explain the cognitive …
disease on human cognition. Several theories have been proposed, to explain the cognitive …
[HTML][HTML] Infectious agents and Alzheimer's disease
T Piekut, M Hurła, N Banaszek, P Szejn… - Journal of Integrative …, 2022 - imrpress.com
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Individuals affected
by the disease gradually lose their capacity for abstract thinking, understanding …
by the disease gradually lose their capacity for abstract thinking, understanding …
Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic
S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …
Elucidating the neuropathologic mechanisms of SARS-CoV-2 infection
M Pacheco-Herrero, LO Soto-Rojas… - Frontiers in …, 2021 - frontiersin.org
The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …
Potential and limits of cannabinoids in Alzheimer's disease therapy
Simple Summary This review was aimed at exploring the potentiality of drugging the
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …
Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care
S Toniolo, M Scarioni, F Di Lorenzo… - Journal of …, 2021 - journals.sagepub.com
Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as
an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …
an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …
A review on SARS-CoV-2-induced neuroinflammation, neurodevelopmental complications, and recent updates on the vaccine development
M Karnik, NM Beeraka, CA Uthaiah, SM Nataraj… - Molecular …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a devastating viral infection caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The incidence and …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The incidence and …
Vascular dysfunctions contribute to the long-term cognitive deficits following COVID-19
Simple Summary Although SARS-CoV-2 primarily affects the upper respiratory system and
the lungs, it can also affect vasculature, leading to the impairment of endothelial and multi …
the lungs, it can also affect vasculature, leading to the impairment of endothelial and multi …